BNP and N‐terminal proBNP are both extracted in the normal kidney
- 22 December 2005
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 36 (1) , 8-15
Abstract
Background Increased plasma concentrations of cardiac‐derived B‐type natriuretic peptide (BNP) and N‐terminal pro‐B‐type natriuretic peptide (proBNP) are both associated with left ventricular dysfunction. Information on the regional elimination of the peptides is, however, still scarce. We therefore examined the renal and peripheral extraction of N‐terminal proBNP and BNP.Materials and methods The study comprised 18 patients with essential arterial hypertension, 51 with cirrhosis, and 18 control patients without kidney or liver disease. All patients underwent a haemodynamic investigation with catheterization of the femoral artery and femoral and renal veins. Blood sampling from the catheters allowed determination of the arteriovenous extraction ratio of N‐terminal proBNP and BNP.Results Neither the peripheral N‐terminal proBNP (13, 11, 19 pmol L−1, NS) nor the BNP plasma concentrations (4, 12, 9 pmol L−1, NS) differed between the patient groups. In addition, similar renal extractions were observed in the groups. The renal extraction of N‐terminal proBNP (0·16) was not different from that of BNP (0·16). In contrast, the N‐terminal proBNP extraction in the lower extremity was markedly lower compared with BNP (0·00 vs. 0·125, P = 0·007).Conclusions A comparable renal elimination of N‐terminal proBNP and BNP is contrasted by a selective extraction of BNP in the lower extremity. Our results suggest a different elimination mechanism in the renal and peripheral circulation, which partly may explain the higher N‐terminal proBNP compared with BNP concentrations in normal plasma.Keywords
This publication has 37 references indexed in Scilit:
- ProBNP‐derived peptides in cardiac diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2004
- Diagnostic and prognostic value of plasma brain natriuretic peptide in non—dialysis-dependent CRFAmerican Journal of Kidney Diseases, 2004
- Diagnosis of heart failure using urinary natriuretic peptidesClinical Science, 2004
- N-Terminal Pro-Brain Natriuretic Peptide After Myocardial InfarctionHypertension, 2002
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- Urinary immunoreactive brain natriuretic peptide in patients with renal diseaseRegulatory Peptides, 1996
- Noninvasive 24-hour ambulatory arterial blood pressure monitoring in cirrhosisHepatology, 1995
- Colchicine inhibits lithocholate-3-O-glucuronide-induced cholestasis in ratsJournal of Hepatology, 1995
- Circulating atrial natriuretic peptide (ANP) and central blood volume (CBV) in cirrhosisLiver International, 1986
- Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.Gut, 1984